Owlet, Inc.
OWLTAbout the company
Owlet, Inc. provides digital parenting solutions in the United States, the United Kingdom, and internationally. The company offers a digital parenting platform that provides real-time data and insights to parents.
Investment snapshot
Positive
1
BUY / PASS
Neutral / negative
2 / 13
NEUTRAL / FAIL
Median fair value
—
No comparable estimates
Models with upside
0 / 17
Positive margin of safety
Key risk
No clean pass — all 16 investors flag at least one profitability criterion
Framework analysis
| Verdict | Meaning |
|---|---|
| BUY | Positive purchase signal: the framework's buy requirements are met. |
| PASS | The company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state. |
| NEUTRAL | Neither a positive nor negative conclusion. It does not mean to hold an existing position. |
| FAIL | The company does not clear the framework's requirements. |
| Ranked | Ranked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL. |
Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.
| Metric | Graham Defensive Value | Buffett Quality Compounder | Lynch GARP | Greenblatt Magic Formula | Piotroski F-Score | Dreman Contrarian Value | Munger Quality Focus | Pabrai Dhandho Framework | Akre Three-Legged Stool | Marks Risk-Aware Value | Ackman Activist Value | Templeton Global Bargain Hunter | Sleep Scale Economies Shared | Asness Systematic Factors | Neff Low-P/E Total Return | Schloss Asset-Value Discipline | O'Shaughnessy Systematic Factor Composite |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Verdict | FAIL | FAIL | FAIL | FAIL · Rank #2250 (Top 72.7%) | PASS | FAIL | FAIL | FAIL | FAIL | FAIL | FAIL | FAIL | FAIL | NEUTRAL | FAIL | FAIL | NEUTRAL |
| Score | |||||||||||||||||
| Analysis | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… |
| Intrinsic Value (annual) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Margin of Safety | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Financial Basis | TTM ended 2026-06-30 · Balance sheet at 2026-06-30 · Annual history · FY 2025 Latest source filing: 2026-08-14 Score computed: 2026-11-14 | Annual history · FY 2025 · TTM ended 2026-06-30 Latest source filing: 2026-08-14 Score computed: 2026-11-14 | Annual history · FY 2025 · Balance sheet at 2026-06-30 · TTM ended 2026-06-30 vs 2025-06-30 · TTM ended 2026-06-30 Latest source filing: 2026-08-14 Score computed: 2026-11-14 | TTM ended 2026-06-30 Latest source filing: 2026-08-14 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2026-03-09 Score computed: 2026-11-14 | Annual history · FY 2025 · TTM ended 2026-06-30 · Balance sheet at 2026-06-30 · Market data at 2026-11-01 Latest source filing: 2026-08-14 Score computed: 2026-11-14 | Qualitative assessment · Annual history · FY 2025 · TTM ended 2026-06-30 · Balance sheet at 2026-06-30 Latest source filing: 2026-08-14 Score computed: 2026-11-14 | Qualitative assessment · Annual history · FY 2025 Latest source filing: 2026-03-09 Score computed: 2026-11-14 | Annual history · FY 2025 · Qualitative assessment · TTM ended 2026-06-30 · Balance sheet at 2026-06-30 Latest source filing: 2026-08-14 Score computed: 2026-11-14 | Annual history · FY 2025 · TTM ended 2026-06-30 · Qualitative assessment Latest source filing: 2026-08-14 Score computed: 2026-11-14 | Annual history · FY 2025 · TTM ended 2026-06-30 · Balance sheet at 2026-06-30 · Market data at 2026-11-01 Latest source filing: 2026-08-14 Score computed: 2026-11-14 | Annual history · FY 2025 · Price history 2026-08-01–2026-11-01 · Balance sheet at 2026-06-30 Latest source filing: 2026-08-14 Score computed: 2026-11-14 | Annual history · FY 2025 · Qualitative assessment Latest source filing: 2026-03-09 Score computed: 2026-11-14 | TTM ended 2026-06-30 · Balance sheet at 2026-06-30 · Price history 2026-08-01–2026-11-01 · Annual history · FY 2025 Latest source filing: 2026-08-14 Score computed: 2026-11-14 | Annual history · FY 2025 · TTM ended 2026-06-30 Latest source filing: 2026-08-14 Score computed: 2026-11-14 | Annual history · FY 2025 · Balance sheet at 2026-06-30 Latest source filing: 2026-08-14 Score computed: 2026-11-14 | TTM ended 2026-06-30 · Annual history · FY 2025 · Price history 2026-08-01–2026-11-01 Latest source filing: 2026-08-14 Score computed: 2026-11-14 |
Where It Passes
Where It Falls Short
- Profitability0% pass✓ 5✗ 30▾
No clean pass — all 16 investors flag at least one profitability criterion
Positive EPS (10 years)0/7 years positive✗GrahamPositive EPS every year for 10 yearsEPS Growth (3-yr avg, 10-yr window)N/A (negative base EPS)✗Graham>= 33% growthNet Income Positive (10+ years)0/7 years positive✗BuffettPositive every year for 10+ yearsROE (up to 5-year arithmetic mean)-169.1%✗Buffett> 15% arithmetic mean (app rule)Operating Margin (10-yr trend)-7.8% (latest)✓BuffettStable or rising over 10 yearsFree Cash Flow Proxy$-39.4M✗BuffettPositive and growingEarnings Variance (10-yr CoV)N/A (negative mean EPS)✗BuffettCoV < 0.3Retained Earnings Effectiveness✗Buffett$1 retained -> > $1 market value createdBasic earnings-growth PEG (dividends excluded)✗Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR✗Lynch15-30% (Fast Grower); > 0% to passROE-38.9%✗Lynch> 15%EBIT / Enterprise Value-8.6%✗Greenblatt> 10%Earnings Yield + ROC AssessmentEY=-8.6%, ROC=-34.6%✗GreenblattBoth EY > 10% and ROC > 25%Net Income / Total Assets-46.34%✗PiotroskiROA > 0ROA Change YoY-25.32% -> -46.34% (delta: -21.02%)✗PiotroskiCurrent ROA > Prior ROA(CFO / Total Assets) vs ROACFO/Assets=-12.60%, ROA=-46.34%✓PiotroskiCFO/Assets > ROAGross Margin Change YoY50.4% -> 50.6%✓PiotroskiImproved YoYPre-Tax Income / Revenue-7.8%✗Dreman>= 8%Net Income / Shareholders' Equity-38.9%✗Dreman> 12%Margin of SafetyP/B=4.9x✗PabraiP/B < 1.5 or P/E < 15Return on Equity-169.1% (3-yr avg)✗AkreROE > 20% (3-year avg)Discount to Intrinsic ValueN/A (negative normalized EPS)✗Marks>= 20% below intrinsic valuePositive Net Income Frequency0/6 years positive✗MarksPositive net income in >= 7 of last 10 yearsOperating Income / Revenue-6.5%✗Ackman>= 15%Net Income / Shareholders Equity-38.9%✗Ackman>= 15%5-Year EPS CAGR✗Templeton> 0% (5-year EPS CAGR)Operating Margin Trend-53.0% (2023) -> -7.8% (2025)✓TempletonNon-negative operating-margin trend over 3 yearsRevenue growth vs. gross and operating margin trendgross margin 41.8% -> 50.6%, operating margin -53.0% -> -7.8%✗SleepRevenue rising; gross margin flat or falling; operating margin holdingNet income / market capitalization-8.97%; #4130/6340 (top 65.1%)✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-sectionGross profit / total assets+67.21%; #375/3702 (top 10.1%)✓AsnessTop 30% of eligible cross-sectionNet income / positive book equity-38.95%; #4066/5226 (top 77.8%)✗AsnessTop 30% of eligible cross-sectionNegative 5-year standard deviation of ROA-0.3823; #4775/5884 (top 81.2%)✗AsnessTop 30% of eligible cross-section3-5 Year Diluted EPS CAGR✗Neff7%-20% annualizedPositive Diluted-EPS Years0/5 years positive✗Schloss>= 70% positive over 5-10 observed years (app rule) - Valuation0% pass✗ 28▾
All 13 investors flag OWLT's valuation
Price / 3-yr avg EPS✗Graham<= 15xPrice-to-Book Ratio4.9x✗Graham<= 1.5xP/E x P/B✗Graham<= 22.5Basic earnings-growth PEG (dividends excluded)✗Lynch< 1.0 (ideally < 0.5)EBIT / Enterprise Value-8.6%✗Greenblatt> 10%Earnings Yield + ROC AssessmentEY=-8.6%, ROC=-34.6%✗GreenblattBoth EY > 10% and ROC > 25%Price / EPS✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)Price / (CFO / Shares)N/A (negative CFPS)✗Dreman< 8xPrice / Book Value per Share4.9x✗Dreman< 1.2x✗Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)Valuation ReasonablenessOE Yield=-42.5%✗MungerP/E < 25 or Owner Earnings Yield > 5%P/E or FCF YieldFCF Yield=-11.0%✗PabraiP/E < 15 or FCF Yield > 10%P/B or P/E vs. Historical AverageP/B=4.9x✗MarksP/E < 15 or P/B < 2.0Discount to Intrinsic ValueN/A (negative normalized EPS)✗Marks>= 20% below intrinsic valuePrice / FCF per ShareN/A (negative FCF)✗Ackman<= 25Price vs. Trailing Low✗Templeton<= 120% of trailing low (certified split-adjusted live window)Net income / market capitalization-8.97%; #4130/6340 (top 65.1%)✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-sectionPositive book equity / market capitalization+0.2302; #4034/6449 (top 62.6%)✗AsnessTop 30% of eligible cross-sectionPrice / Diluted EPS✗NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)(EPS CAGR % + Dividend Yield %) / P/E✗Neff> 0.7 (Neff's published traditional edge)Price / Tangible Book Value per Share5.25x✗SchlossP/TBV <= 1.00x (app cutoff)Book Value per Share Change✗SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)Revenue / market capitalization+1.1426; #1629/5247 (top 31.0%)✗OshaughnessyTop 10% of eligible cross-section(Operating cash flow - capex) / market capitalization-8.48%; #3171/4519 (top 70.2%)✗OshaughnessyTop 10% of eligible cross-sectionTrailing six-month price return through the evaluation date✗OshaughnessyTop 10% of eligible cross-section - Cash Flow0% pass✓ 1✗ 11▾
No clean pass — all 10 investors flag at least one cash flow criterion
Free Cash Flow Proxy$-39.4M✗BuffettPositive and growingFCF Positive and Growing$-11.1M✗LynchPositive and growingOperating Cash Flow$-10.8M✗PiotroskiCFO > 0(CFO / Total Assets) vs ROACFO/Assets=-12.60%, ROA=-46.34%✓PiotroskiCFO/Assets > ROAPrice / (CFO / Shares)N/A (negative CFPS)✗Dreman< 8xP/E or FCF YieldFCF Yield=-11.0%✗PabraiP/E < 15 or FCF Yield > 10%FCF Positive0/6 years FCF positive✗MarksPositive FCF in majority of recent years(OCF - CapEx) / Market Cap-9.2%✗Ackman>= 4%Price / FCF per ShareN/A (negative FCF)✗Ackman<= 25Positive Operating Cash Flow frequency0/6 years positive✗SleepPositive OCF in >= 70% of available yearsOperating Cash Flow - Capital Expenditures$-8.5M✗Neff> $0 (app proxy for a strong fundamental case)(Operating cash flow - capex) / market capitalization-8.48%; #3171/4519 (top 70.2%)✗OshaughnessyTop 10% of eligible cross-section - Growth0% pass✓ 1✗ 12▾
No clean pass — all 8 investors flag at least one growth criterion
EPS Growth (3-yr avg, 10-yr window)N/A (negative base EPS)✗Graham>= 33% growthBasic earnings-growth PEG (dividends excluded)✗Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR✗Lynch15-30% (Fast Grower); > 0% to passInventory Growth vs Revenue GrowthInv: 37.6% vs Rev: 27.9%✗LynchInventory growth < Revenue growthEPS Growth Direction$-0.48 (2020) -> $-1.57 (2024)✗DremanPositive over recent yearsEPS CAGR✗Dreman> 5% annualizedPositive Net Income Frequency0/6 years positive✗MarksPositive net income in >= 7 of last 10 years3yr Median Revenue Growth35.4%✓Ackman>= 5%Positive EPS Growth Frequency2/4 years with positive EPS growth✗AckmanPositive EPS growth in >= 3 of last 5 years5-Year EPS CAGR✗Templeton> 0% (5-year EPS CAGR)Revenue growth vs. gross and operating margin trendgross margin 41.8% -> 50.6%, operating margin -53.0% -> -7.8%✗SleepRevenue rising; gross margin flat or falling; operating margin holding5-year Revenue CAGR7.0%✗SleepCAGR > 7%3-5 Year Diluted EPS CAGR✗Neff7%-20% annualized - Verdicts7% pass✓ 1✗ 14▾
Split decision: 13 FAIL · 2 NEUTRAL · 1 PASS
Overall verdict✗GrahamFAIL (2/9)✗BuffettFAIL (1/9)✗LynchFAIL (1/7)✗GreenblattRank #2250✓PiotroskiPASS (F-Score 4)✗DremanFAIL (2/11)✗MungerFAIL (0/4)✗PabraiFAIL (0/3)✗AkreFAIL (1/6)✗MarksFAIL (0/5)✗AckmanFAIL (3/9)✗TempletonFAIL (3/8)✗SleepFAIL (1/6)•AsnessNEUTRAL (Not ranked)✗NeffFAIL (1/6)✗SchlossFAIL (2/7)•OshaughnessyNEUTRAL (Not ranked) - Efficiency13% pass✓ 2✗ 9▾
7 of 8 flag OWLT's efficiency — Graham, Buffett, Greenblatt +4 more
Current Ratio1.64✗Graham>= 2.0ROIC (3-5 yr avg)✗Buffett> 10%ROIC - WACC✗BuffettPositive (WACC = 10%)EBIT / (NWC + Net Fixed Assets)-34.6%✗Greenblatt> 25%Current Ratio Change YoY1.27 -> 1.85✓PiotroskiIncreased YoYRevenue / Total Assets Change YoY1.58x -> 1.23x✗PiotroskiImproved YoYCurrent Assets / Current Liabilities1.64✓Dreman> 1.5Return on Invested Capital-14.6%✗Munger> 15%ROIC (high and growing)FY2023: ROIC=unavailable; FY2024: ROIC=unavailable; FY2025: ROIC=-20.3%✗AkreLatest 3 consecutive FYs: ROIC > 15% in eachReinvestment Rate x ROICN/A (non-positive net income)✗AkreReinvestment Rate * ROIC > 10%ROIC (5-year)0/2 years above 12% (latest -20.3%)✗SleepROIC > 12% in a majority of years - Debt & Leverage50% pass✓ 9✗ 6▾
6 of 12 pass — Buffett, Lynch, Munger +3 more object
LT Debt vs Net Current AssetsLT Debt $0.0M vs NCA $34.5M✓GrahamLT Debt <= Net Current AssetsDebt/Equity & Interest CoverageD/E: 0.74, IC: -52.3x✗BuffettD/E < 0.5 AND Interest Coverage > 5xTotal Debt / Equity0.74✗Lynch< 0.33Cash - Long-term Debt$30.9M✓LynchPositive preferredLT Debt / Total Assets Change8.75% -> 2.88%✓PiotroskiDecreased YoYCurrent Assets / Current Liabilities1.64✓Dreman> 1.5✓SchlossCurrent ratio >= 1.50x (app cutoff)Total Debt / Shareholders' Equity0.74✓Dreman< 0.8✓Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✓SchlossD/E < 1.00xDebt Levels0.74✗MungerDebt/Equity < 0.5✗AkreDebt/Equity < 0.3Interest Coverage & Debt/EBITDAIC=-52.3x, D/EBITDA=N/A✗MarksInterest Coverage > 3x; Debt/EBITDA < 4xTotal Debt / Shareholders Equity0.74✓Ackman<= 1.0Negative debt-to-equity (higher means less debt)-0.7374; #2904/4210 (top 69.0%)✗AsnessTop 30% of eligible cross-section
Business & financials
Financial snapshot: annual FY 2025. Current investor scores may use newer quarterly data.
Company Profile
Financial Snapshot
Shareholder Return
Fiscal 2025
Issued 71.3% of shares last year.
- Buybacks
- —
- Dividends
- —
Company Financials
Latest TTM and quarters alongside annual years
TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.
The latest annual period end is unavailable. Showing the latest fiscal cycle’s quarters; quarter and annual columns may overlap. Quarterly shows the full quarter history.
| Metric | TTM · 2026-09-30 2025-10-01 – 2026-09-30 Sources · derived quarter valuesDerived from cumulative filings: revenue, net income, operating income, gross profit, ebit, pre tax income, interest expense, operating cash flow, depreciation amortization, capex. | Q3 FY 2026 2026-07-01 – 2026-09-30 Sources · derived quarter valuesDerived from cumulative filings: operating cash flow, depreciation amortization, capex. | Q2 FY 2026 2026-04-01 – 2026-06-30 Sources · derived quarter valuesDerived from cumulative filings: operating cash flow, depreciation amortization, capex. | Q1 FY 2026 2026-01-01 – 2026-03-31 Sources | FY 2025Sources
| FY 2024Sources
| FY 2023Sources
| FY 2022Sources
| FY 2021Sources
|
|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $100.5Mcurrent | -- | -- | -- | $134.5Mest. | -- | -- | -- | -- |
| Revenue | $113.3M↑14% | $30.4M↓5% | $33.9M↑30% | $22.5M↑6% | $105.7M↑35% | $78.1M↑45% | $54.0M↓22% | $69.2M↓9% | $75.8M |
| Operating Income | -$7.4M↑31% | $1.2M↓1% | $1.7M↑191% | -$5.5M↓106% | -$8.3M↑59% | -$20.2M↑29% | -$28.6M↑66% | -$84.6M↓52% | -$55.8M |
| Net Income | -$11.7M↑70% | $1.4M↓66% | -$620.0K↑98% | -$3.3M↓210% | -$39.7M↓217% | -$12.5M↑62% | -$32.9M↑59% | -$79.3M↓11% | -$71.7M |
| EPS (Diluted) | -- | $0.01↑117% | $-0.05↑98% | $-0.25↓327% | -- | $-1.57↑65% | $-4.53↓538% | $-0.71↑37% | $-1.13 |
| Gross Margin | 55.7%↑7% | 53.8%↑6% | 64.4%↑26% | 54.5%↑2% | 50.6%↑1% | 50.4%↑20% | 41.8%↑24% | 33.7%↓27% | 46.2% |
| Operating Margin | -6.6%↑39% | 4.0%↑4% | 5.1%↑170% | -24.5%↓93% | -7.8%↑70% | -25.9%↑51% | -53.0%↑57% | -122.3%↓66% | -73.6% |
| ROE | -44.3%↓161% | — | — | — | -208.4%↓595% | 42.1%↓52% | 87.7%↓88% | 746.0%↑674% | -129.9% |
| Total Debt | $11.0M↓56% | $11.0M↓56% | $17.1M↓17% | $18.8M↑35% | $13.0M↑11% | $11.7M↓23% | $15.2M↑47% | $10.4M↓37% | $16.5M |
| Shareholders' Equity | $26.5M↑149% | $26.5M↑149% | $23.1M↑139% | $21.0M↑181% | $19.0M↑164% | -$29.8M↑21% | -$37.5M↓253% | -$10.6M↓119% | $55.2M |
| Current Ratio | 1.91↑68% | 1.91↑68% | 1.64↑43% | 1.71↑44% | 1.85↑46% | 1.27↑43% | 0.89↑15% | 0.77↓61% | 1.97 |
| Debt / Equity | 0.42↑190% | 0.42↑190% | 0.74↑312% | 0.89↑266% | 0.68↑274% | -0.39↑3% | -0.40↑58% | -0.97↓425% | 0.30 |
| Operating Cash Flow | -$3.4M↑53% | $2.2M↑200% | -$92.0K↑96% | -$5.0M↑15% | -$10.8M↑4% | -$11.2M↑52% | -$23.5M↑71% | -$81.4M↓101% | -$40.6M |
| Free Cash Flow | -$4.5M↑39% | $1.8M↑183% | -$631.0K↑73% | -$5.1M↑15% | -$11.1M↑2% | -$11.2M↑52% | -$23.5M↑71% | -$82.0M↓98% | -$41.5M |
Score history
Historical Score Timeline
Industry peers
Industry Peers
Similar companies in Measuring and Control Equipment
OWLT vs Peers — Financial Grading
| Company | Market Cap | Price | Revenue | Net Income | ROE | D/E | Op. Margin | Curr. Ratio | Graham | Buffett | Lynch | Greenblatt | Piotroski | Dreman |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| THERMO FISHER SCIENTIFIC INC.TMO | $259.4B | $700.22 | $44.6B | $6.7B | 12.6% | 0.74 | 17.4% | 1.89 | 3/9 | 3/9 | 3/7 | 1/3 | F-Score 5 | 7/11 |
| DANAHER CORP /DE/DHR | $163.9B | $233.02 | $24.6B | $3.6B | 6.9% | 0.35 | 19.1% | 1.87 | 3/9 | 4/9 | 2/7 | 1/3 | F-Score 5 | 4/11 |
| WATERS CORP /DE/WAT | $90.5B | $460.25 | $3.2B | $642.6M | 25.1% | 0.55 | 25.4% | 1.73 | 1/9 | 4/9 | 1/7 | 0/3 | F-Score 4 | 5/11 |
| AGILENT TECHNOLOGIES, INC.A | $49.0B | $173.96 | $6.9B | $1.3B | 19.3% | 0.45 | 21.3% | 1.96 | 2/9 | 5/9 | 3/7 | 1/3 | F-Score 5 | 5/11 |
| ROPER TECHNOLOGIES INCROP | $47.5B | $479.98 | $7.9B | $1.5B | 7.7% | 0.47 | 28.3% | 0.52 | 2/9 | 3/9 | 3/7 | 0/3 | F-Score 6 | 4/11 |
| COHERENT CORP.COHR | $43.0B | $218.15 | $5.8B | $49.4M | 0.9% | 0.69 | 1.6% | 2.19 | 3/9 | 1/9 | 0/7 | 0/3 | F-Score 4 | 4/11 |
| TERADYNE, INCTER | $39.0B | $249.55 | $3.2B | $554.0M | 19.8% | 0.07 | 20.4% | 1.75 | 2/9 | 6/9 | 4/7 | 1/3 | F-Score 6 | 6/11 |
| ILLUMINA, INC.ILMN | $31.3B | $207.01 | $4.3B | $850.0M | 31.2% | 0.73 | 18.6% | 2.08 | 2/9 | 1/9 | 3/7 | 1/3 | F-Score 8 | 5/11 |